AOD-9604 (5mg Vial) Dosage Protocol Synthetic hGH (176-191) fragment studied for lipolysis research/educational dosing reference
BPC-157 is not FDA approved as a standard medication, and the FDA has identified concerns around compounded BPC-157, including possible immunogenicity risk, peptide-related impurities, and limited safety information for certain routes of administration
This means a single 10mg vial can theoretically cover the first 12 to 13 weeks of a standard escalation protocol, using roughly 7mg through that period
It plays a role in the production of the neurotransmitters serotonin and dopamine, as well, which is why it can strongly impact mood
Reference: Systematic Review BPC-157 in Orthopaedic Sports Medicine (2024)
All three compounds are co-formulated into a single sealed 70mg vial and released against one batch certificate